Peter Rieckmann

A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis

Gavin Giovannoni, Stuart D. Cook, Kottil Rammohan et al. · New England Journal of Medicine · 2010 · 969 citations · Full text

Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters

Peter Flachenecker, Tania Kümpfel, Boris Kallmann et al. · Multiple Sclerosis Journal · 2002 · 615 citations

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

Vittorio Martinelli, M. Rodegher, Lucia Moiola et al. · The Lancet · 2009 · 585 citations

Neurological Disorder, Medicine, Clinical Neurology +8

Monocyte/macrophage differentiation in early multiple sclerosis lesions

Wolfgang Brück, Phyllis Porada, S. Poser et al. · Annals of Neurology · 1995 · 522 citations

PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS

G. Francis, Richard AC Hughes, John King et al. · DIAL (Catholic University of Leuven) · 2001 · 472 citations